S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Pulmonary Fibrosis Foundation Hosts Virtual Symposium for Patients

Navigating a diagnosis of pulmonary fibrosis or interstitial lung disease often leaves families searching for both medical clarity and community support. On November 12–13, 2026, the Pulmonary Fibrosis Foundation is hosting a virtual symposium designed to bridge the gap between clinical research and the daily realities of patient care.

Pulmonary Fibrosis Foundation Hosts Virtual Symposium for Patients
Photo: Bio & News

The two-day event connects patients, caregivers, and transplant recipients with specialists to discuss the latest advancements in treatment and long-term disease management. Dr. Amy Hajari Case, Chief Medical Officer at the PFF, emphasized that the symposium provides more than just clinical data, offering the practical tools and emotional resources essential for those living with these complex conditions.

Sessions will cover a broad spectrum of needs, ranging from updates on current clinical trials and medication management to guidance on supplemental oxygen and post-transplant life. The program also dedicates space to the challenging aspects of the patient journey, including navigating care decisions and coping with grief. By moving the event to a virtual format, the foundation aims to ensure that expert insights remain accessible to the entire community regardless of location. Registration for the symposium is currently open through the foundation's official website.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!